Some aspects of intensivists' thinking on arterial carbon dioxide tension (PaCO 2 ) have changed dramatically over the past 30 years, while other facets are unaltered 1 . As a Fellow in critical care, I spent considerable time manipulating the ventilator to ensure that my patients' PaCO 2 remained within the normal range. Any increase in PaCO 2 above 45 mmHg was assumed to be harmful and evidence of laziness on the part of the fellow.
This thinking was overturned by a revolutionary study published in 1984 by Darioli . The authors note that there is little evidence that hypercapnia is harmful to critically ill patients; indeed, there is much evidence that hypercapnia can aid lung-repair mechanisms in certain circumstances 7 . Also in the current issue of Anaesthesia and Intensive Care, Joseph et al report the findings of a study undertaken to determine whether use of a tracheostomy achieves physiological benefits in mechanically ventilated patients 8 . Specifically, does a tracheostomy enhance carbon dioxide clearance compared with use of an endotracheal tube? And does it lower airway resistance? They answer 'no' to both questions.
Common sense would dictate that use of a tracheostomy, which bypasses a large portion of the upper airways, should reduce dead space. Studies conducted in cadavers reveal that a tracheostomy decreases anatomical dead space volume by about half 9 . But Joseph et al found that a tracheostomy had no effect on dead space to tidal volume ratio:
41±12.6% before and 40±14.6% after tracheotomy (P=0.75). Likewise, PaCO 2 did not budge: 35.4±6.96 mmHg before tracheotomy and 36.8±8.86 mmHg afterwards (P=0.55).
Why did the investigators not find a decrease in dead space? Here we need to distinguish geometric volume, as measured by filling an airway with water, and functional volume or physiologic dead space. Physiological dead space is defined as that part of the tidal volume that does not participate in gas exchange, a mixture of anatomic dead space in the conducting airways and pathologic alveolar dead space resulting from lung disease. If we form a mental picture of ventilation being achieved by bulk flowwith air moving down the trachea (and bronchi) and occupying the entire width of the airway-we expect a tracheostomy to decrease total dead space. Back in 1915, however, Henderson et al showed that this commonsensical picture of CO 2 clearance is wrong. In the days before technetium scans and radioactive labelling, Henderson blew tobacco smoke down a glass tube and found that smoke did "not move along the tube in a cylindrical column, filling the tube from side to side, but in the form of a very thin spike" 10 . When the investigator stopped the puff by placing his tongue against the opening of the tube, "the spike breaks instantly everywhere; and the tube is seen to be filled from side to side with a mixture of smoke and air". Henderson's demonstration that dead space operates as a thin spike, rather than an unvarying volume occupying the entire width of the airway, explains why Joseph et al failed to find a decrease in PaCO 2 following a tracheotomy.
The papers by Joseph et al and Tiruvoipati et al have one message in common: physicians should not devote undue efforts to lowering PaCO 2 in most critically ill patients. At first blush, this might suggest that intensivists should not bother themselves too much about hypercapnia. That interpretation would be dangerous. Here we need to make a distinction between diagnosis and therapy. In many instances, therapeutic manoeuvres designed to lower PaCO 2 may cause more harm than benefit. In contrast, PaCO 2 is vitally important in diagnosis, acting as a harbinger of impending disaster.
Interpretation of PaCO 2 readings in a spontaneously breathing patient needs to be grounded in an understanding of the respiratory control system. The respiratory controllers-respiratory centres, neurons and muscles that produce alveolar ventilation-maintain a stable PaCO 2 across wide fluctuations in CO 2 production 11 . CO 2 production can vary tenfold during exercise, yet PaCO 2 remains virtually unchanged. This stability is achieved by the exquisite sensitivity of the chemoreceptor system, typically assessed by measuring the change in minute ventilation as a patient rebreathes CO 2 . The normal range in healthy adults is 0.5-8.0 litre/minute/mmHg (1.5-5.0 in 80% of subjects) 11 . Thus, an increase in PaCO 2 of 3 mmHg should cause minute ventilation to increase by about 10 litres per minute (or double). Failure to observe such an increase signifies significant respiratory impairment, either because the patient won't breathe secondary to significant depression of respiratory motor output or the patient can't breathe consequent to increased mechanical load or respiratory muscle weakness.
The need for prudent interpretation of PaCO 2 readings in a spontaneously breathing patient is illustrated by a case on which I recently consulted. A young woman was admitted to a medical ward with acute pancreatitis for which she was receiving morphine at frequent intervals. Five days after admission, the patient experienced a cardiac arrest that resulted in irreversible hypoxic brain injury. An arterial blood gas obtained two days before the arrest revealed the following values: pH 7.29, PaCO 2 44 mmHg, PaO 2 76 mmHg, bicarbonate 18 mEq/litre and oxygen saturation 93%. In the progress notes, the medical resident noted "Patient saturating well on two litres of oxygen with nasal cannula. PCO 2 levels within normal limits. Continue present management".
It is true that the patient's PCO 2 was within the normal range, but the recorded PaCO 2 signalled considerable compromise. The marked metabolic acidosis was producing substantial stimulation of the central chemoreceptors 11 . Consequently, the patient's PaCO 2 should have been much lower than 44 mmHg-more like 35-37 mmHg. The PaCO 2 of 44 mmHg represented significant respiratory depression. When the staff further increased the dosage of morphine, they markedly increased the patient's susceptibility to further respiratory depression, hypoventilation and hypoxaemia.
When thinking about PaCO 2 in critically ill patients, intensivists may adopt a laissez-faire approach towards hypercapnia in the ventilated patient, but a different mindset-more alert, and even a little radical-is needed when assessing PaCO 2 in a spontaneously breathing patient.
